Population Pharmacokinetics and Evaluation dosing of Ceftolozane-Tazobactam in Critically ill Patients
Not Applicable
- Conditions
- Acute kidney disease due to sepsis
- Registration Number
- JPRN-UMIN000043201
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with a history of anaphylaxis-like symptoms due to ceftolozan tazobactam 2) Patients diagnosed as pregnant at the time of consent 3) Patients who participate in or participate in other evaluations
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method